GE HealthCare stock (US36266G1076): Norges Bank stake and AI nuclear medicine push in focus

GE HealthCare shares on Nasdaq are drawing attention after a new 13F filing showed Norges Bank built a sizable stake, while the United States-based medtech company highlighted AI-enabled nuclear medicine and imaging innovations ahead of a key industry meeting.

GE HealthCare shares on the Nasdaq under the ticker GEHC were in focus for United States investors on 06/01/2026 after a recent regulatory filing showed that Norges Bank built a significant position in the company and management continued to promote artificial intelligence-driven nuclear medicine and imaging technologies in its home market.

According to a Form 13F filing with the U.S. Securities and Exchange Commission covering the fourth quarter, Norges Bank purchased 7,266,808 GE HealthCare shares with an aggregate value of about USD 596 million, underscoring institutional interest in the Chicago-based medical technology group, as reported by MarketBeat on 06/01/2026.

The stock traded on Nasdaq in the United States, where it is part of the American medical technology universe, and the latest activity by Norway's central bank adds another large institutional holder to the register, according to the same 13F disclosure that summarized positions as of the end of the fourth quarter.

GE HealthCare also kept attention on its technology roadmap in the United States by highlighting new artificial intelligence-enabled tools and nuclear medicine innovations around the time of the 2026 SNMMI Annual Meeting, emphasizing how it intends to compete in advanced diagnostic imaging.

In parallel, industry coverage noted that GE HealthCare has been training clinicians to work with AI-based medical imaging and decision-support tools, reinforcing the company's push to embed software and analytics more deeply into its installed base of systems worldwide.

As of: 06/01/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: GE HealthCare
• Sector/industry: Medical technology and healthcare imaging solutions
• Headquarters/country: Chicago, United States
• Core markets: North America, Europe, Asia-Pacific
• Key revenue drivers: Imaging systems, patient monitoring, diagnostics and related services
• Home exchange/listing venue: Nasdaq (GEHC)
• Trading currency: USD

GE HealthCare: core business model

GE HealthCare concentrates on diagnostic imaging, monitoring and digital tools for hospitals and clinics, generating revenue mainly from equipment sales, software and recurring service contracts across its global installed base.

Insider activity and ownership structure

While the recent Form 13F filing does not classify Norges Bank as an insider, the fund's purchase of more than 7.2 million GE HealthCare shares worth approximately USD 596 million in the fourth quarter adds a new, sizable institutional owner alongside existing asset managers and index funds, according to the MarketBeat summary of the SEC filing dated 06/01/2026.

Institutional participation such as Norges Bank's position can influence float distribution and trading liquidity in the United States, although day-to-day share-price movements still reflect a combination of earnings expectations, sector news and macroeconomic factors that affect the broader healthcare equipment space.

Conclusion

The disclosure that Norges Bank accumulated a multi-hundred-million-dollar position in GE HealthCare in the fourth quarter puts a spotlight on institutional ownership in the United States and may shape how investors view the stock's shareholder base.

At the same time, GE HealthCare's ongoing work to roll out AI-enabled nuclear medicine, PET imaging and clinician training initiatives illustrates how the company is positioning its technology portfolio in the competitive global medtech market.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.